Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
US Market
Holding BCAX?
Track your performance easily

Bicara Therapeutics Inc. (BCAX) Financial Statements

17 Followers

Bicara Therapeutics Inc. Financial Overview

Bicara Therapeutics Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Bicara Therapeutics Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Dec 22
Income Statement-
Total Revenue---
Gross Profit---
EBIT---
EBITDA---
Net Income Common Stockholders---
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 203.85M$ 230.44M$ 4.16M
Total Assets$ 208.78M$ 233.98M$ 6.70M
Total Debt$ 300.00K$ 285.00K$ 0.00
Net Debt$ -203.56M$ -230.16M$ -4.16M
Total Liabilities$ 16.28M$ 15.47M$ 23.98M
Stockholders Equity$ 192.50M$ 218.51M$ -17.28M
Cash Flow-
Free Cash Flow---
Operating Cash Flow---
Investing Cash Flow---
Financing Cash Flow---
Currency in USD

Bicara Therapeutics Inc. Earnings and Revenue History

Bicara Therapeutics Inc. Debt to Assets

Bicara Therapeutics Inc. Cash Flow

Bicara Therapeutics Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis